Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aricept for Gait and Balance in Parkinson's Disease
NCT01521117Phase 4Completed
- Sponsor
- Oregon Health & Science University
- Start
- Dec 2011
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of donepezil in Parkinson's disease (PD), sponsored by Oregon Health & Science University. Primary endpoint: Sensory Organization Test Composite at 6 weeks. Started Dec 2011; status: completed.
02
Drugs
donepezil
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01521117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01521117.